Correlation Between Chunghwa Precision and Synmosa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chunghwa Precision and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chunghwa Precision and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chunghwa Precision Test and Synmosa Biopharma, you can compare the effects of market volatilities on Chunghwa Precision and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chunghwa Precision with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chunghwa Precision and Synmosa Biopharma.

Diversification Opportunities for Chunghwa Precision and Synmosa Biopharma

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Chunghwa and Synmosa is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Chunghwa Precision Test and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Chunghwa Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chunghwa Precision Test are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Chunghwa Precision i.e., Chunghwa Precision and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Chunghwa Precision and Synmosa Biopharma

Assuming the 90 days trading horizon Chunghwa Precision Test is expected to under-perform the Synmosa Biopharma. In addition to that, Chunghwa Precision is 2.77 times more volatile than Synmosa Biopharma. It trades about -0.02 of its total potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.03 per unit of volatility. If you would invest  3,375  in Synmosa Biopharma on October 25, 2024 and sell it today you would lose (35.00) from holding Synmosa Biopharma or give up 1.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Chunghwa Precision Test  vs.  Synmosa Biopharma

 Performance 
       Timeline  
Chunghwa Precision Test 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chunghwa Precision Test are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Chunghwa Precision showed solid returns over the last few months and may actually be approaching a breakup point.
Synmosa Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Chunghwa Precision and Synmosa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chunghwa Precision and Synmosa Biopharma

The main advantage of trading using opposite Chunghwa Precision and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chunghwa Precision position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.
The idea behind Chunghwa Precision Test and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing